Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT
· Real-Time Price · USD
7.68
-0.99 (-11.42%)
At close: Aug 15, 2025, 3:59 PM
7.83
1.95%
After-hours: Aug 15, 2025, 07:47 PM EDT
Sagimet Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 35K | 34K | 34K | n/a | n/a | n/a | 32K | 33K |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.97M | -34K | -34K | n/a | n/a | n/a | -32K | -33K |
Operating Income | -11.93M | -19.86M | -18.2M | -16.9M | -10.59M | -8.77M | -9.47M | -7.45M | -7.06M | -6.76M | -7.39M | -7.69M | -7.24M | -8.74M | -4.8M |
Interest Income | n/a | 1.69M | 1.99M | 2.28M | 2.47M | 2.14M | 1.31M | 1.09M | 271K | 180K | 193K | 218K | 136K | 6K | 6K |
Pretax Income | -10.39M | -18.18M | -16.2M | -14.62M | -8.12M | -6.63M | -8.15M | -6.35M | -6.79M | -6.59M | -7.2M | -7.47M | -7.1M | -8.73M | -5.55M |
Net Income | -10.39M | -18.18M | -16.2M | -14.62M | -8.12M | -6.63M | -8.15M | -6.35M | -6.79M | -6.59M | -7.2M | -7.47M | -7.1M | -8.73M | -5.55M |
Selling & General & Admin | 4.68M | 4.52M | 3.98M | 4.25M | 4.28M | 3.51M | 3.81M | 4.49M | 2.38M | 2.28M | 1.54M | 848K | 867K | 2.88M | 1.45M |
Research & Development | 7.25M | 15.34M | 14.22M | 12.65M | 6.31M | 5.26M | 5.66M | 4.96M | 4.68M | 4.49M | 5.85M | 6.84M | 6.37M | 5.86M | 3.35M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2K | n/a | n/a | n/a | 2K | n/a |
Operating Expenses | 11.93M | 19.86M | 18.2M | 16.9M | 10.59M | 8.77M | 9.47M | 9.45M | 7.06M | 6.76M | 7.39M | 7.69M | 7.24M | 8.74M | 4.8M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.93M | 19.86M | 18.2M | 16.9M | 10.59M | 8.77M | 9.47M | 9.45M | 7.06M | 6.76M | 7.39M | 7.69M | 7.24M | 8.74M | 4.8M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -38K | -39K |
Shares Outstanding (Basic) | 32.2M | 32.2M | 32.2M | 32.14M | 31.91M | 29.04M | 18.19M | 18.19M | 22.17M | 22.17M | 22.17M | 22.17M | 22.17M | 22.17M | 22.17M |
Shares Outstanding (Diluted) | 32.2M | 32.2M | 32.2M | 32.14M | 31.91M | 29.04M | 18.19M | 18.19M | 22.17M | 22.17M | 22.17M | 22.17M | 22.17M | 22.17M | 22.17M |
EPS (Basic) | -0.32 | -0.56 | -0.5 | -0.45 | -0.25 | -0.23 | -0.45 | -0.35 | -0.31 | -0.3 | -0.32 | -0.34 | -0.32 | -0.39 | -0.25 |
EPS (Diluted) | -0.32 | -0.56 | -0.5 | -0.45 | -0.25 | -0.23 | -0.45 | -0.35 | -0.31 | -0.3 | -0.32 | -0.34 | -0.32 | -0.39 | -0.25 |
EBITDA | -11.93M | -19.86M | -16.2M | -16.9M | -10.59M | n/a | -6.78M | -7.45M | -6.75M | -6.55M | n/a | n/a | n/a | -8.7M | -4.8M |
EBIT | -10.39M | -19.86M | -16.2M | -16.9M | -10.59M | -8.77M | -9.47M | -7.45M | -7.06M | -6.76M | -7.39M | -7.69M | -7.24M | -8.74M | -4.8M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | 8.77M | 9.47M | n/a | 34K | 34K | 7.39M | 7.69M | 7.24M | 32K | 33K |